| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |